The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
October 3rd 2024
A study reveals that individuals with schizophrenia spectrum disorders experience high rates of comorbid mental health conditions and receive minimally adequate treatment.
September 26th 2024
September 20th 2024
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Executive Function Disorder and ADHD
November 17th 2013Executive function disorder and ADHD share several overlapping symptoms, and the presence of executive function impairment is often associated with a diagnosis of ADHD. Clinicians should be aware of the testing modalities that can help accurately identify executive function disorder, and also be aware of the limitations of current medications when it comes to mitigating symptoms.
Schizophrenia: Crafting a New Approach to Treatment Tolerability
November 16th 2013Genotyping and access to more genetic information about patients may allow clinicians to minimize side effects associated with treatment for schizophrenia by choosing antipsychotic agents based on their unique molecular binding profiles and using the lowest effective doses.
Integrating Non-pharmacologic Modalities into Major Depressive Disorder Treatment
November 16th 2013Evidence shows that interventional approaches such as transcranial magnetic stimulation, electroconvulsive therapy, deep brain stimulation, and bright light therapy, coupled with mindfulness-based cognitive therapy, can be an effective part of treatment for major depressive disorder.
The Changing Face of Bipolar Care: Initial Results of the MedRisk Study
November 16th 2013Study looks at an integrated care model for treating bipolar depression that incorporates a multidisciplinary care team, individualized lifestyle interventions, focused patient education, weight loss and nutrition counseling, and efforts to promote treatment adherence.
Expert Tips for Assessing, Diagnosing, and Managing Bipolar Depression
November 15th 2013Presentation at the 2013 NEI Psychopharmacology Congress noted potential "red flag" symptoms and events that indicate increased risk of bipolar depression, and discussed several medication options for effectively managing this mental health disorder.
Major Disasters and the Mental Health Community
November 15th 2013Planning and preparation prior to a disaster, developing networks of contacts with other medical personnel and facilities, avoiding overburdening medical staff and personnel in the aftermath of a disaster, and effectively treating PTSD and other mental health disorders are the keys to disaster preparedness.
Hyponatremia Correction in Cirrhosis May Improve Cognition, Reduce Caregiver Burden
November 6th 2013Investigating the association between hyponatremia and cognition in patients with cirrhosis, Jasmohan Bajaj, MD, and colleagues from Virginia Commonwealth University presented results showing reduced brain edema, better quality of life (QOL), and less caregiver burden with the use of the aquaretic tolvaptan.
EMR Analysis Reveals Significant Predictors of Fibromyalgia Diagnosis
Noting that it takes an average of 5 years before a fibromyalgia patient receives a diagnosis, researchers conducted a retrospective data analysis to identify significant variables that may enable earlier detection and diagnosis of fibromyalgia.
Memantine with Donepezil Superior to Single Treatment in Moderate to Severe Alzheimer's Disease
October 16th 2013Study results show that patients who received combination treatment demonstrated improvements in cognition, function, and behavioral outcomes compared to treatment with either medication alone or placebo.
New Biomarker May Detect Parkinson's Disease before Symptoms Start
Researchers have determined that higher alpha-synuclein ratios are associated with greater autonomic dysfunction and more advanced disease stages, which suggests that an increased alpha-synuclein level may be a useful biomarker in Parkinson's disease patients.
Anxiety and Depression Are Often Comorbid with Psychosis in Parkinson's Disease
October 15th 2013Study results indicate a significant correlation between depression and hallucination in patients with Parkinson's disease, while anxiety is a significant predictor for both the number and severity of hallucinations.
No Evidence of Efficacy Found in Review of Gluten- and Casein-Free Diets in Children with Autism
October 15th 2013A literature search found no well-documented evidence showing that implementing a gluten-and-casein-free diet in children with autism produces statistically significant differences in autism-related behaviors.